On the level of the enzyme eNOS, transgenic overexpression in mice was shown to increase metabolic health, and protect from HFD-induced obesity [93], and genetic variations of eNOS are associated with T2DM and aspects of the MS in humans. Here, NOS3 is linked to type 2 diabetes mellitus.